Metabolic bone disease
A diseases are caused by disturbances
in the metabolism of calcium and
phosphate resulting in inadequate
mineralization of bone matrix.
The fundamental problem in metabolic bone
diseases is an imbalance between bone formation and resorption in the normal
remodeling process of bones
Conditions considered to be metabolic bone
disorders
Osteomalacia and rickets
- These are disorders of bone in which the essential defect is failure of calcification in newly formed bone.
- Rickets is referred to disease affecting the growing children
- Osteomalacia is a disease of adults (mainly lactating females).
Osteomalacia and rickets Causes:
Most commonly:
Reduced dietary intake of calcium and Vit
D.
Limited exposure to sunlight.
Less commonly:
Malabsorption ( disease in the small
intestine).
Liver disease ( defective synthesis).
Renal disease ( increased excretion).
Rickets :
Clinical effects;
Bone pain and tenderness
weakness of bones with, tendency of
distortion
Microfractures (linear partial fractures)
Stunting of growth
Bowing of lower limbs
Enlargement of costochondral junctions.
Frontal bossing
Pigeon breast deformity (due to pull of
respiratory muscles)
In females, permanent deformity of pelvic
bone leads to serious difficulty during child birth.
Deformity or curvature of the spine
Treatment of Rickets
Vitamin D. therapy: 300,000-600,000 iu orally
or IM in 2-4 divided doses over one day.
High dose vit D 2000-5000 iu orally for
4-6wks followed by 400iu daily orally as maintenance.
Adequate dietary Calcium & phosphorus
provided by milk, formula & other dairy products.
Symptomatic hypocalcaemia need IV ca as
20mg/kg or ca gluconate as 100mg/kg as a bolus, followed by oral calcium
tapered over 2-6 weeks.
Osteomalacia
Age: adults
Defective mineralization of newly formed bone
during bone remodeling.
Soft bone – result from impaired
mineralization in matrix bone.
Site: vertebral
bodies and femoral neck
Osteomalacia
Causes:
Inadequate concentration of extrcellular fluid
phosphate &/or calcium.
Deficiency of vit. D dietary plus inadequate
sunlight exposure.
Malabsorption; gastric surgery, celiac
disease, defect bile salt production.
Renal disease; decrease conversion of 25 (OH)
D à 1, 25 (OH)2
D.
Hepatic disease; less common à decrease 1, 25 (OH)2
D.
Due to phenytoin, barbiturate
Clinical manifestation
Bone pain, deformities, fracture.
Muscle weakness, growth retardation.
Muscle pain & tenderness (sub clinical
fracture).
Proximal myopathy à waddling gait.
In children à
characteristic picture of rickets.
PAGET DISEASE
It is a localized & progressive disorder
characterized by increase bone remodeling, bone hypertrophy with abnormal
structure
Cause unknown ?virus- males > females
Common in Europe à 3% of general population >
50 years old
PAGET DISEASE
This unique skeletal disease is characterized
by: repetitive episodes of regional osteoclastic activity and bone resorption (osteolytic
stage), followed by exuberant bone formation (mixed osteoclastic-osteoblastic
stage) , and finally by an apparent exhaustion of cellular
activity (osteosclerotic stage).
The net effect of this process is a gain in
bone mass; however, the newly formed bone is
disordered and lacks strength.
PAGET DISEASE MORPHOLOGY
an initial phase of osteoclastic activity, hypervascularity, and bone
loss.
a mixed osteoclastic-osteoblastic phase, which ends with a predominance
of osteoblastic activity.
a burnt-out quiescent osteosclerotic stage.
Paget's Disease: clinical manifestations
Bone pain
Joint pain
Deformity
Spontaneous fractures
Paget Disease
Renal Osteodystrophy
is a bone disease that occurs when your
kidneys fail to maintain the proper levels of calcium and phosphorus in your
blood. It's a common problem in people with kidney disease and affects 90
percent of dialysis patients .
Renal Osteodystrophy
is a bone disease that occurs when your
kidneys fail to maintain the proper levels of calcium and phosphorus in your
blood. It's a common problem in people with kidney disease and affects 90
percent of dialysis patients .
Renal Osteodystrophy
Renal failure
Phosphate retention
reduce 1,25 (OH)2 vit D production à Reduce à
Ca absorption à
low Ca à
increase PTH
Increase bone resorption
Treatment
Controlling PTH levels prevents calcium from
being withdrawn from the bones. Usually, overactive parathyroid glands are
controllable with a change in diet, dialysis treatment, or medication. The drug
cinacalcet hydrochloride (Sensipar), approved by the Food and Drug
Administration in 2004, lowers PTH levels by mimicing calcium. If PTH levels
can't be controlled, the parathyroid glands may need to be removed surgically
Osteoporosis
Definition:
The most common metabolic bone disorder
Is a disorder characterized by reduction of
bone mass resulting in increased porosity
The structural changes predispose to bone
fragility and fractures.
Osteoporosis
Osteoporosis is often called a "silent
disease" because bone loss occurs
without symptoms.
Osteoporosis is a disease of the elderly
(>65
years).
A
woman’s hip fracture risk equals her
combined risk of breast, uterine and
ovarian cancer.
Normal versus osteoporotic bone
Prevalence
Osteoporosis is a major public health problem
worldwide. During 2006, ten million
individuals in the U.S. are estimated to have
the disease.
Of the ten million, eight million are women
and two million are men.
Morbidity and mortality
Osteoporosis leads to:
Loss of height.
Fracture of the vertebrae leading to
kyphosis.
Fracture of the hip (neck of the femur)
leading to death and disability.
Morbidity and mortality
Osteoporosis fractures are a major
cause of morbidity and mortality in
elderly.
1.66 million hip fractures occur each
year worldwide.
15-20% of hip fractures lead to death
within the year following the fracture.
50% of hip fractures lead to significant
disability.
Risk Factors
Certain people are more likely to develop
this disease than others.
Age
Estrogen deficiency
Testosterone deficiency
Family history/genetics
Female sex
Low calcium/vitamin D intake
Poor exercise
Smoking
Risk Factors
Alcohol
Low
body weight/anorexia
Hyperparathyroidism
Prednisone use
Liver and renal disease (think about vit.
D synthesis)
Low sun exposure
Medications (antiepileptic, heparin)
Hemiplegia , CVA/ immobility
Pathophysiology
In healthy individuals who get enough
calcium and physical activity, bone
production exceeds bone destruction up
to the age of 30. After that, bone
destruction exceeds production.
Skeletal mass starts to decline in
women after the age of 35, and in men
after the age of 45.
Pathophysiology
People typically lose bone as they age,
despite consuming the recommended
intake of calcium. This is due to several
factors, including genetic factors,
physical inactivity, and lower levels of
circulating hormones (estrogen and
testosterone).
Pathophysiology
Postmenopausal women account for
80%
of all cases of osteoporosis
because estrogen production declines
rapidly at menopause.
Men are also at risk of developing
osteoporosis, but this occurs 5-10 years
later than women, as testosterone
levels do not fall abruptly.
Osteoporotic Fractures in Women Compared With
Other Diseases
A
Osteoporosis
Prevention
Building strong bones in childhood and
adolescence is the best defense.
A balanced diet rich in calcium and Vitamin D
Weight bearing exercise
A healthy lifestyle with no smoking or
excessive alcohol intake.
Bone density testing and medication when
appropriate.
Prevention
-Avoid long periods of immobilization
-Estrogen
supplementation.
-Adequate
dietary calcium intake before age of 30
appears to reduce the risk of osteoporosis.
-Calcium
supplementation in life may moderate
the reduction of bone loss.
Public Health Recommendations
1-1.5
g of daily calcium
400-800
of vitamin D daily
Weight-bearing exercise
Discourage smoking
Recommendations
Get adequate calcium intake from milk,
yogurt and low-oxalate vegetables
rather than cheese.
Maintain an adequate store of vitamin D
whether through diet, exposure to
sunshine, diet or supplements
Recommendations
Get an adequate protein intake. Make
plant foods your main source of protein.
Include omega-3 F.A.s in your diet.
Reduce sodium intake. Don’t smoke.
Limit soft drinks and caffeine intake.
Avoid high Retinol consumption which
simulate osteoclast activity mainly in
elderly.
Get vitamin A from carotenes.
Get regular weight-bearing physical exercise.
Recommendations
Do not add salt at table.
Decrease
salt during cooking.
Limit the intake of salty foods (olives,
pickles, chips, cheese, salted nuts,
salted fishes and salted red pepper).
Decrease the intake of canned foods,
stock cubes and commercial biscuits
Recommendations
Nacl increases urinary calcium excretion
due to competition between Na and Ca
for kidney reabsorption.
Take adequate vitamin D.
Magnesium helps calcium absorption
from the gut.
Oxalate, phytic acid, and caffeine
reduces calcium absorption from the
gut.
0 comments:
Post a Comment